Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.

See also Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D’Angelo A, Tognoni G, Barbui T. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). This issue, pp 848–53; Anderson DR. Oral anticoagulation for the antiphospholipid antibody syndrome: can we now say less is more? This issue, pp 846–7; Rickles FR, Marder VJ. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No. This issue, pp 842–3; Scully M-F. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes, This issue, pp 840–1.